Rockefeller Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Rockefeller Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,800	Closed	-$8K	–	2077
2023 Q1	$8K	Sell	20,800 -1,501	-7%	-$1.15K	﹤0.01%	1962
2022 Q4	$26K	Buy	22,301 +1,500	+7%	+$2.44K	﹤0.01%	2705
2022 Q3	$48K	Buy	20,801 +2,700	+15%	+$7.07K	﹤0.01%	2377
2022 Q2	$40K	Sell	18,101 -2,000	-10%	-$13.9K	﹤0.01%	2402
2022 Q1	$193K	Sell	20,101 -75,957	-79%	-$681K	﹤0.01%	1710
2021 Q4	$952K	Buy	96,058 +21,900	+30%	+$218K	﹤0.01%	1061
2021 Q3	$733K	Buy	74,158 +64,158	+642%	+$629K	﹤0.01%	1118
2021 Q2	$98K	Buy	+10,000	New	+$97.5K	﹤0.01%	1813

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Rockefeller Capital Management's GRNA Position: Q2 2023 in Review

Rockefeller Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 20,800 shares — an estimated $8K sold.

Rockefeller Capital Management first reported a position in GRNA in Q2 2021 and held it in 8 quarters. The position peaked at $952K in Q4 2021. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Rockefeller Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Rockefeller Capital Management sold 20,800 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $8K.
Rockefeller Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 8 quarters.
Rockefeller Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $952K in Q4 2021.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.